Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05027464 · ClinicalTrials.gov registry record · NA

Developing and Testing a COVID-19 Vaccination Acceptance Intervention

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
338,718
Enrollment target

NCT05027464: Completed NA study, sponsored by VA Office of Research and Development.

NCT05027464 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 338,718 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05027464, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
338,718 participants
Enrollment target

Study Summary

The COVID-19 pandemic has resulted in significant loss of life and suffering with total case and death counts increasing daily, particularly with the emergence of the delta variant. COVID-19 vaccines have proven highly effective in preventing severe illness, hospitalization, and death. Nevertheless, according to VA data sources, only 56% of all U.S. Veterans have been vaccinated to date, largely owing to vaccine hesitancy and lack of access to vaccination. Thus, there is a critical need for evidence-based interventions to increase COVID-19 vaccine acceptance and access among Veterans, many of whom are vulnerable to poor outcomes of COVID-19. The overall goal of this study is to increase COVID-19 vaccination in Veterans of VISNs 16 and 21 who remain unvaccinated either because of vaccine hesitancy or lack of access to COVID-19 vaccine. Specifically, the investigators will test a COVID-19 Vaccine Acceptance Intervention (Motivational Interviewing) plus Implementation Facilitation.

Interventions

  • BEHAVIORAL Moving to COVID-19 Vaccine Acceptance Intervention

Trial Details

FieldValue
Enrollment Target 338,718 participants
Start Date 2022-04-05
Est. Completion 2024-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05027464

The ClinicalTrials.gov registry entry for NCT05027464 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 338,718 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Moving to COVID-19 Vaccine Acceptance Intervention is the first listed.

NCT05027464 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05027464 about?

NCT05027464 is a clinical study titled "Developing and Testing a COVID-19 Vaccination Acceptance Intervention". The COVID-19 pandemic has resulted in significant loss of life and suffering with total case and death counts increasing daily, particularly with the emergence of the delta variant. COVID-19 vaccines have proven highly effective in preventing severe illness, hospitalization, and death. Nevertheless,...

What is the current status of trial NCT05027464?

This trial is currently completed. It is a NA study. The enrollment target is 338,718 participants. The study started on 2022-04-05. Estimated completion is 2024-09-30.

What interventions are being tested in trial NCT05027464?

The interventions under investigation include: Moving to COVID-19 Vaccine Acceptance Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05027464?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.